Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term response. Found 6 abstracts

Cook JR, Goldman B, Tubbs RR, Rimsza L, Leblanc M, Stiff P, Fisher R. Clinical Significance of MYC Expression and/or "High-grade" Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas A SWOG S9704 Correlative Study. American Journal of Surgical Pathology. 2014 Apr;38(4):494-501.   PMCID: PMC 3955880
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. International Journal of Radiation Oncology Biology Physics. 2007 May;68(1):111-8.
Kampranis SC, Damianova R, Atallah M, Toby G, Kondi G, Tsichlis PN, Makris AM. A novel plant glutathione S-transferase/peroxidase suppresses Bax lethality in yeast. Journal of Biological Chemistry. 2000 Sep 22;275(38):29207-16.
Schier R, Bye J, Apell G, McCall A, Adams GP, Malmqvist M, Weiner LM, Marks JD. Isolation of high-affinity monomeric human Anti-c-erbB-2 single chain Fv using affinity-driven selection. Journal of Molecular Biology. 1996 Jan 12;255(1):28-43.
Yao KS, Xanthoudakis S, Curran T, Odwyer PJ. Activation of Ap-1 and of a Nuclear Redox Factor, Ref-1, in the Response of Ht29 Colon-Cancer Cells to Hypoxia. Molecular and Cellular Biology. 1994 Sep;14(9):5997-6003.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term response

response mammalian-cells rearrangements B-cell lymphoma polymerase-chain-reaction criteria immune- binding- fos ALKALINE-PHOSPHATASE uv NSCLC meta-analysis bone-marrow-transplantation in-situ hybridization identification prednisone dasatinib tyrosine kinase inhibitor chronic myelogenous repair enzyme fragments imatinib transplantation acids NECK-CANCER properties proapoptotic protein bax CONCURRENT CYTOPROTECTOR AMIFOSTINE transferases complete cytogenetic phage display libraries programmed cell-death monoclonal-antibodies non-hodgkins-lymphoma vincristine diffuse large B-cell lymphoma unclassifiable with features intermediate between DLBCL and BL locally advanced protein HYPERFRACTIONATED RADIATION FRACTIONATED RADIOTHERAPY hematologic response filamentous phage features jun MYC transcriptional regulation classification single chain Fv bcl2 escherichia-coli hypersensitive phage antibody libraries therapy antibody donor lymphocyte infusions patients receiving imatinib amifostine cytogenetic immunohistochemistry fatty- tumor PHASE-II c-erbB-2 doxorubicin chronic myeloid-leukemia COMBINED-MODALITY THERAPY rituximab plus cyclophosphamide RADIATION-THERAPY mitochondrial control affinity cancer-therapy by-passing immunization maturation nad(p)h-quinone reductase gene variable domains protection nilotinib apoptosis karyotyping dna-binding activity imatinib mesylate stem-cell transplantation chain shuffling permeability transition pore non-small-cell lung cancer CHEMOTHERAPY leukemia hydrogen-peroxide BONE-MARROW allogenic HSCT
Last updated on Wednesday, February 05, 2020